The Response To Ajmaline Provocation in Healthy Subjects

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT02933437

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 2
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
St George's, University of London (from the registry)
Registry
  • NCT NCT02933437
  • EudraCT 2016-004277-41
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02933437. Allocation not applicable; no masking; primary purpose diagnostic. Start 2017-10-22 (actual); primary completion 2019-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Response To Ajmaline Provocation in Healthy Subjects
Condition
Brugada Syndrome
Condition
Sudden Death
Intervention (Drug)
Ajmaline
Lead sponsor
St George's, University of London (class: other)

Record details

Record id
cardio:ct-nct02933437
Content hash
a55d8a9f79bc74d6a8d87809a92c4bdaaafccac94d72587286604d46567028a2